>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
April 29, 2013
MEDICURE REPORTS 3RD QTR FINANCIAL RESULTS FOR FISCAL 2013 Read more
February 28, 2013
Dr. Albert D. Friesen to File Early Warning Report Read more
January 28, 2013
MEDICURE REPORTS 2ND QTR FINANCIAL RESULTS FOR FISCAL 2013 Read more
Sign up to receive email updates such as Press Release nofications and other company news.